文献速递脊柱关节炎

护士主导的系统性合并症筛查项目对中轴型脊柱关节炎患者的影响:COMEDSPA 前瞻性随机对照一年试验

Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial.
PubMed 文献 · Semin Arthritis Rheum · 2020-05-27

COMEDSPA 是一项前瞻性、随机、对照、开放、为期12个月的试验,纳入502例中轴型脊柱关节炎(axSpA)患者,评估护士主导的系统性合并症筛查项目对合并症管理的影响。主要结局为加权合并症管理评分(0-100,0为最佳管理)一年后的变化,结果显示两组无差异;但主动组在疫苗接种、癌症筛查和骨质疏松管理方面符合推荐的患者比例显著更高。

要点

  • 护士主导的单次门诊系统筛查未改善加权合并症管理评分。
  • 主动组流感疫苗接种率28.6% vs 对照组9.9%(p<0.01)。
  • 主动组骨密度检查率22.6% vs 8.7%,维生素D补充启动率51.9% vs 9.4%(p<0.01)。

核心结论

  • 单次护士主导的系统性合并症筛查项目在短期内可提高axSpA患者对疫苗接种、癌症筛查和骨质疏松管理推荐的依从性,但未改善加权合并症管理评分。

研究设计与样本

  • 前瞻性、随机、对照、开放、12个月试验(NCT02374749),纳入502例根据风湿科医生诊断的axSpA连续患者,主动组252例、对照组250例。

主要发现

  • 一年后两组加权合并症管理评分无差异。
  • 主动组流感疫苗接种率28.6% vs 对照组9.9%(p<0.01),肺炎球菌疫苗接种率40.0% vs 21.1%(p=0.04)。
  • 主动组皮肤癌筛查率36.3% vs 17.2%(p=0.04)。
  • 主动组骨密度检查率22.6% vs 8.7%(p<0.01),维生素D补充启动率51.9% vs 9.4%(p<0.01)。

关键数值与推荐

  • 加权合并症管理评分范围0-100,0代表最佳管理。
  • 主动组与对照组在疫苗接种、癌症筛查和骨质疏松管理方面符合推荐的患者比例存在显著差异。

临床怎么用

  • 可考虑采用护士主导的单次门诊访视对axSpA患者进行系统性合并症筛查,以提升疫苗接种、癌症筛查和骨质疏松管理的推荐依从性。

局限性

  • 研究为开放标签设计,对照组接受的教育项目未在本文中呈现,随访仅12个月,为短期结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of a nurse-led program of systematic screening for the management (detection/prevention) of comorbidities. METHODS: Prospective, randomized, controlled, open, 12-month trial (NCT02374749). PARTICIPANTS: consecutive patients with axial Spondyloarthritis (axSpA) (according to the rheumatologist) THE PROGRAM: A nurse collected data on comorbidities during a specific outpatient visit. In the event of non-agreement with recommendations, the patient was informed and a specific recommendation was given to the patient (orally and in a with a detailed written report). Patients were seen after one year in a nurse-led visit. TREATMENT ALLOCATION: random allocation (i.e. either this program or an educational program not presented here and considered here as the control group). MAIN OUTCOME: change after one year of a weighted comorbidity management score (0 to 100 where 0= optimal management). RESULTS: 502 patients were included (252 and 250 in the active and control groups, respectively): age: 47±12 years, male gender: 63%, disease duration: 14±11y. After one year, no differences were observed in a weighted comorbidity management score. However, the number of patients in agreement with recommendations was significantly higher in the active group for vaccinations (flu vaccination: 28.6% vs. 9.9%, p<0.01; pneumococcal vaccination:40.0% vs. 21.1%,p=0.04), for cancer screening (skin cancer screening: 36.3% vs. 17.2%, p=0.04) and for osteoporosis (bone densitometry performed: 22.6% vs. 8.7%, p<0.01; Vitamin D supplementation initiation: 51.9% vs. 9.4%, p<0.01). CONCLUSIONS AND RELEVANCE: This study suggests the short-term benefit of a single-visit nurse-led program for systematic screening of comorbidities for its management in agreement with recommendations, even in this young population of patients with axSpA.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Molto A, Gossec L, Poiraudeau S, et al. Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial. Semin Arthritis Rheum. 2020. PMID: 32521324. doi:10.1016/j.semarthrit.2020.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。